by The global teledermatology market size is forecasted to reach from US$ 12.70 billion in 2021 to US$ 67.43 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 20.4% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The teledermatology market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decision to sustain growth through the assessment period.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1445
The global teledermatology market gained a rapid momentum in 2020 owing to the outbreak of COVID-19 pandemic. The growing demand for the convenient healthcare services and products among the global consumers is boosting the growth of the global teledermatology market. The rising adoption of the telehealth platforms among the global consumers has positively impacted the growth of the tele-dermatology market. Moreover, the growing prevalence of skin diseases and skin related problems is significantly fueling the demand for the tele-dermatology across the globe.
As per the Global Burden of Skin Disease project, the skin disease is the fourth largest cause of non-fatal disease around the globe. Further, it is estimated that around 30% to 70% of the global population is suffering from various skin diseases. Thus, the growing burden of various skin diseases coupled with the rising adoption of the digital health platforms are the major factors behind the growth of the global market.
Scope of the Teledermatology Market
| Report Coverage | Details |
| Market Size In 2020 | USD 12.70 Billion in 2021 |
| Growth Rate from 2021 to 2030 | CAGR of 20.4% |
| Revenue Projection by 2030 | USD 67.43 Billion |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
COVID-19 Impact
Increasing Demand for Teleconsultations amid Pandemic to Aid Growth
Increased internet penetration has shifted doctor consultation on online platforms. In these tough times, teleconsultation has emerged as the biggest savior. People are following lockdown and social distancing regulations to avoid the spread of the virus.
For instance, a survey by the American Association of Dermatology published in 2020 mentioned that around 43% of the decline was reported in usual consultation due to the outbreak of the virus. This decline has led to a huge uptake of teleconsultations services, including dermatologists. All these factors are likely to favor the market during the forecast period.
Key Market Developments
In April 2020, Sakhiya Skin Clinic introduced skin care treatment through tele-dermatology platforms which is free of cost. This will boost the adoption of tele-dermatology among the consumers in India.
In June 2021, Hims& Hers acquired Apostrophe, a dermatology start-up. This acquisition will improve Hims& Hers to offer personalized dermatology services to the consumers.
In March 2020, the Ministry of Health and Family Welfare and NITI Aayog introduced an official guideline for the use of telemedicine, in India. This will foster the adoption and growth of the tele-dermatology platforms in India.
The various developmental strategies like acquisition and new product launches with latest and innovative features fosters market growth and offers lucrative growth opportunities to the market players.
Competitive Landscape Analysis:
Some of the leading companies operating in the teledermatology market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.
Major companies operating in this report are
- Diagnosis
- Honeywell Life Care Solutions
- Philips Healthcare
- AMD Global Telemedicine Inc.
- GE Healthcare
- Aerotel Medical Systems
- Click Diagnostics
- Dermlink
- Allscripts Healthcare Solutions Inc.
- McKesson Corporation
Segments Covered in the Report
By Type
- Products
- Services
- Teleconsultation
- Telemonitoring
- Tele-education
- Others
By Modality
- Store-and –Forward
- Video Conferencing
By End User
- Healthcare units
- Homecare
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Why should you invest in this report?
If you are aiming to enter the global teledermatology market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for teledermatology are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1445
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Teledermatology Market
5.1. COVID-19 Landscape: Teledermatology Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Teledermatology Market, By Product
8.1. Teledermatology Market, by Product Type, 2021-2030
8.1.1. Products
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Services (Teleconsultation, Telemonitoring, Tele-education, Others)
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Teledermatology Market, By Modality
9.1. Teledermatology Market, by Modality, 2021-2030
9.1.1. Store-and –Forward
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Video Conferencing
9.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Teledermatology Market, By End User
10.1. Teledermatology Market, by End User, 2021-2030
10.1.1. Distribution Channel
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Homecare
10.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Teledermatology Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Modality (2019-2030)
11.1.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Modality (2019-2030)
11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Modality (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Modality (2019-2030)
11.2.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Modality (2019-2030)
11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Modality (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Modality (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Modality (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Modality (2019-2030)
11.3.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Modality (2019-2030)
11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Modality (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Modality (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Modality (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Modality (2019-2030)
11.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Modality (2019-2030)
11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Modality (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Modality (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Modality (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Modality (2019-2030)
11.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Modality (2019-2030)
11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Modality (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)
Chapter 12. Company Profiles
12.1. Diagnosis
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Honeywell Life Care Solutions
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Philips Healthcare
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. AMD Global Telemedicine Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. GE Healthcare
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Aerotel Medical Systems
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Click Diagnostics
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Dermlink
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Allscripts Healthcare Solutions Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. McKesson Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1445
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
